MARK T KEATING, M.D.
Osteopathic Medicine at Mass Ave, Cambridge, MA

License number
Massachusetts 209012
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
250 Mass Ave, Cambridge, MA 02139
Phone
(617) 871-4059

Organization information

See more information about MARK T KEATING at bizstanding.com

Mark T Keating MD

100 Technology Sq #6655, Cambridge, MA 02139

Categories:
Infectious Disease Physicians & Surgeons
Phone:
(617) 871-7698 (Phone)

Professional information

Mark T Keating Photo 1

Dr. Mark T Keating, Cambridge MA - MD (Doctor of Medicine)

Specialties:
Cardiology
Address:
250 Massachusetts Ave, Cambridge 02139
(617) 871-4059 (Phone)
Certifications:
Cardiovascular Disease, 1985, Internal Medicine, 1983
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Johns Hopkins University School Of Medicine
Graduated: 1980
Johns Hopkins Hospital
Graduated: 1981
University Of California


Mark Taylor Keating Photo 2

Mark Taylor Keating, Cambridge MA

Specialties:
Internist
Address:
250 Massachusetts Ave, Cambridge, MA 02139
100 Technology Sq, Cambridge, MA 02139
Education:
Johns Hopkins University, School of Medicine - Doctor of Medicine*
UCSF Medical Center - Fellowship - Cardiology*
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine*, American Board of Internal Medicine Sub-certificate in Cardiovascular Disease (Internal Medicine)*


Mark Keating Photo 3

C5 Antigens And Uses Thereof

US Patent:
2010016, Jul 1, 2010
Filed:
Mar 19, 2008
Appl. No.:
12/532261
Inventors:
Braydon Charles Guild - Cambridge MA, US
Mark Taylor Keating - Cambridge MA, US
Mariusz Milik - Cambridge MA, US
Dmitri Mikhailov - Cambridge MA, US
Michael Roguska - Cambridge MA, US
Igor Splawski - Cambridge MA, US
Kehao Zhao - Cambridge MA, US
International Classification:
A61K 39/395, A61K 38/16, C07K 7/08, C07K 7/06, C07H 21/04, A61P 27/02, C12N 15/63, C12N 5/10, C12P 21/06
US Classification:
4241331, 4241391, 514 12, 530326, 530328, 536 231, 4353201, 435325, 435 691
Abstract:
The present invention pertains to the use of a complement inhibitor in methods of treatment of ocular disorders and the use of a complement inhibitor in the manufacture of a medicament in the treatment of an ocular disorder.